PHARMACEUTICALS MARKET SWITZERLAND:
Now in its 23rd edition, this publication appeared as a purely online version in 2016. It is a collection of data and information on a wide variety of aspects of the pharmaceutical market in Switzerland, including key data from Interpharma companies. All individual graphics are available for download.
The global expenditure of Interpharma member companies in 2015 amounted to almost 90 billion francs, of which around 7 billion was spent in Switzerland. Research and development investments far outweigh pharmaceutical sales in Switzerland. Research-based companies in Switzerland spent about twice as much on R&D as they earned here in sales. In 2015, the pharma market grew by 5.3% compared with the previous year to around 5.4 billion francs. In past years, the market had stagnated. The growth came from new and innovative medicines, especially for those for hepatitis C, which can cure this infectious disease in more than 90% of cases.
HEALTHCARE SYSTEM SWITZERLAND:
This publication appears once a year with the latest facts and figures on health indicators, healthcare costs and how they are financed in Switzerland. In addition, all individual graphics are online and available for download.
In its 35th edition, this publication includes the following information. For example: in 2013, the increase in healthcare costs at 2.5 percent was less than in the previous year (+4.4%). These costs ran to about 69.2 billion francs in 2013. Inpatient treatment accounted for the largest proportion of healthcare costs at 45.2%. The greatest increase compared with 2012 was seen in the cost for outpatient care, which rose by 6.7%. This accounted for 34.2% of total costs. By contrast, the cost of medicines as a share of the total healthcare cost fell further to a new low of 9.1% (2012: 9.2%).
SWISS HEALTHCARE AND PHARMACEUTICAL MARKET
This publication is an English “best-of” version of the above two brochures, which is only available online. It shows the structure, links and funding streams of Switzerland’s healthcare system along with the latest statistics on the pharmaceuticals market of Switzerland.